Substrate stiffness (or rigidity) of the extracellular matrix has important functions in numerous pathophysiological processes including fibrosis. Emerging data support a role for both a mechanical signal, for example, matrix stiffness, and a biochemical signal, for example, transforming growth factor β1 (TGFβ1), in epithelial-mesenchymal transition (EMT), a process critically involved in fibrosis. Here, we report evi- 
(EMT) is a cell differentiation process by which polarized epithelial cells undergo biochemical/molecular changes, losing their cell polarity and cell-cell adhesion and gaining migratory capacity, invasiveness and elevated resistance to apoptosis, thereby assuming a mesenchymal phenotype. [9] [10] [11] [12] [13] EMT has essential functions in fundamental cellular processes including embryogenesis, development, tissue repair and oncogenesis. [9] [10] [11] [12] [13] However, unchecked and exacerbated EMT can contribute to various pathological conditions such as metastasis and tissue fibrosis. [9] [10] [11] [12] [13] Fibrotic diseases including pulmonary, liver and skin fibrosis are characterized by an increase in the invasion and migration of mesenchymal cells across a stiffened ECM associated with induction of EMT. [12] [13] [14] Transforming growth factor β1 (TGFβ1)-induced EMT in primary human keratinocytes and altered expression of various EMT markers in skin tissues from scleroderma, keloids and melanoma patients have recently been demonstrated, indicating a link between EMT and skin fibrosis and oncogenesis. [15] [16] [17] [18] [19] Mechanical cues, for example, stiffness, in the ECM can influence cellular functions such as cell spreading, motility, differentiation, proliferation, and apoptosis, which are also regulated by TGFβ1. 7, [20] [21] [22] [23] Emerging data support a role for matrix stiffness in EMT in epithelial cells. 16, [21] [22] [23] Zarkoob et al 16 have demonstrated specific effect of matrix stiffness on keratinocyte colony formation. Furthermore, it has been reported that calcium signalling and expression of specific Ca
2+
-permeable ion channels are involved in induction of EMT. [24] [25] [26] [27] [28] However, role of matrix stiffness and/or calcium signalling-induced EMT in skin keratinocytes has not been reported. Although the signalling mechanisms underlying EMT have been well studied, the identity of a matrix stiffness-sensing plasma membrane receptor/channel and the molecular mechanisms by which matrix stiffness signals are transmitted and propagated to drive EMT remain to be determined. Recently, we reported that transient receptor potential vanilloid 4 (TRPV4), a mechanosensitive Ca 2+ -permeable channel, is associated with skin and lung fibrosis.
TRPV4 regulates both biochemical (TGFβ1)-and mechanical (matrix stiffness) stimulus-induced lung and dermal myofibroblast differentiation and contributes to the development of in vivo pulmonary and skin fibrosis in murine models. [29] [30] [31] However, the specific role of TRPV4 in EMT in normal primary epidermal keratinocytes has not been determined.
Transient receptor potential vanilloid 4, a member of the TRP superfamily, is ubiquitously expressed in various cell types including skin keratinocytes and fibroblasts. [29] [30] [31] [32] [33] [34] Published work by our group and others showed that TRPV4 is activated by a wide variety of physical and biochemical stimuli including changes in osmolarity, temperature, mechanical stress, UVB exposure, growth factors and metabolites of arachidonic acid. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] TRPV4 was shown to function as a mechanosensor in response to cyclical stretching of cells, mechanical forces applied to β1 integrins in cell surface or dynamic loading in chondrocytes. 34, [40] [41] [42] Structurally, TRPV4 contains a number of potential regulatory domains and protein-interaction sites, including phosphoinositide 3-kinase (PI3K) and Src homology 2 recognition domains, putative protein kinase C phosphorylation sites, PDZ domains and an N-terminal ankyrin repeat region. [29] [30] [31] [32] [33] [34] Numerous mutations in TRPV4 have been associated with human diseases including skeletal dysplasia and sensory and motor neuropathies. 32, 33 TRPV4 is linked to multiple physiological and pathological functions including sheer stress detection in blood vessels, development of joint diseases, skeletal malformations, pain sensation and osteoclast differentiation in bone. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [43] [44] [45] [46] [47] [48] Published data from our laboratory and others showed that in mice TRPV4 deletion is associated with altered blood pressure and vasodilatory responses, vascular permeability, bladder function, lung injury and fibrosis and skin fibrosis. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [43] [44] [45] [46] [47] [48] It has been shown that TRPV4 activation increases Ca 2+ influx in human keratinocytes and promotes cell-cell junction formation between these cells, whereas TRPV4 antagonism inhibits development of transepithelial resistance in cultured human keratinocytes. 38, 39 However, a potential role of TRPV4 mechanosensing in EMT and the intracellular molecular pathway by which EMT signals are transmitted/propagated has not been reported.
A variety of biomarkers are associated with EMT in vitro and in vivo. [9] [10] [11] [12] [13] For example, E-cadherin (ECAD) is expressed in epithelial cells, and its expression is decreased during EMT. [9] [10] [11] [12] [13] In general, loss of ECAD expression promotes EMT. The switch from ECAD to N-cadherin (NCAD), which is expressed in mesenchymal cells, is a marker for the progress of EMT. [9] [10] [11] [12] [13] Increased expression of α-smooth muscle actin (α-SMA) in myofibroblasts during EMT is also a mesenchymal marker. [9] [10] [11] [12] [13] TGFβ1 is a well studied EMT and profibrotic mediator associated with both myofibroblast differentiation in vitro and of fibrogenesis of many organs including skin. 53, [57] [58] [59] [60] Reports also suggest crosstalk between YAP/TAZ signalling and TGFβ1 signalling. 54, 59, 60 In this study, we sought to determine the role of TRPV4 in EMT processes. We found that epidermal keratinocytes sense mechanical (stiffness) and biochemical (TGFβ1) stimuli via TRPV4 channels, and assume a mesenchymal phenotype. We also obtained in vivo evidence that TRPV4 KO mice are protected from bleomycin-induced Transforming growth factor β1 is known to induce EMT in keratinocytes. 15 Recent evidence from our group suggests a link between TRPV4 activation and TGFβ1 signals that mediate fibroblast differentiation. [29] [30] [31] Previous reports have documented that calcium signalling is involved in EMT in many cell types. [24] [25] [26] [27] [28] However, the identity of a plasma membrane calcium channel and 
| TRPV4 deletion blocks EMT marker expression in a mouse model of bleomycin-induced skin fibrosis
We previously reported that TRPV4 KO mice are protected from pro-fibrotic effects of bleomycin in lung and skin, 29, 30 and bleomycin has been shown to cause EMT in skin and pulmonary fibrosis model. 17, 62 To determine whether TRPV4 deficiency could also suppress EMT in an experimental model of skin fibrosis, we employed the bleomycin-induced skin fibrosis model, and analysed expression of EMT markers between bleomycin or phosphate-buffered saline (PBS) treated TRPV4 KO and WT mice. Dual immunofluorescence staining of skin sections from bleomycin-or PBS-treated TRPV4 KO mice showed significant reductions in the expression of mesenchymal markers (α-SMA and NCAD) compared to control WT mice (Figure 5A,B) . Furthermore, we examined the colocalization of TRPV4
with EMT markers in bleomycin treated skin tissues of fibrotic mice. Recent evidence suggests that matrix stiffness and TGFβ1 cooperate to induce renal fibrogenesis in a YAP/TAZ-dependent manner. 63 Previously, it was reported that YAP and TAZ pre-dominantly localize to the nucleus to drive EMT under high stiffness. 58 However, the identity of a matrix stiffness sensing mechanotransduction receptor/channel and the mechanism by which mechanosensing sig- 
| Deletion of TRPV4 channel blocks AKT activation required for EMT
Activation of the PI3K/AKT pathway is a central promoter of EMT in many cell types. 64, 65 The PI3K/AKT pathway can be activated in either a TGFβ1-dependent or -independent manner. [49] [50] [51] It has been shown that activation of the PI3K/AKT pathway is up-regulated by stiff matrices. 23, 66 We found that TGFβ1-induced activation of Smad-2/3 proteins in a time-dependent manner in both WT and TRPV4 KO NMEKs ( Figure 8A,B) . Furthermore, we found that endogenous Epithelial-mesenchymal transition has important functions in fundamental cellular and pathophysiological processes including wound healing, tissue fibrosis and oncogenesis in numerous organs such as skin, liver, kidney and lungs. [9] [10] [11] [12] [13] Emerging data support an essential role for both a mechanical signal, for example, matrix stiffness, and a biochemical signal, for example, TGFβ1, in EMT. 16, [21] [22] [23] However, the initial critical events in cell-matrix interactions and the elicited intracellular molecular pathway by which pro-fibrotic/EMT signals are transduced and maintained are not fully understood. It has been
shown that physical and biochemical microenvironmental cues can control the degree and duration of fibrosis-associated EMT. 22, [57] [58] [59] In fibrotic tissues, the elastic modulus of normal soft tissues (0.1-2 kPa) can reach as high as 20-100 kPa. 8, 22, 60, 67 Culturing and growing cells in a compliant or stiff matrix environment or in an environment with an elastic modulus similar to that of the normal tissue of origin, induce gene and protein expression, and thereby, produce phenotypes and functions that may not be seen when cells are cultured on plastic or glass surfaces, which are non-physiologically stiff (elastic modulus in the range of GPa). 7, 20 In this study, we studied normal mouse keratinocytes on collagen-coated polyacrylamide hydrogels, adjusting substrate stiffness in culture, which enabled us to determine the effect of normal (compliant = 0.5- Yes-associated protein and TAZ transcription cofactors, the key effectors of the Hippo pathway, are known to control organ size, growth, differentiation and EMT. [52] [53] [54] [55] [56] [57] [58] [59] [60] It has been shown that YAP/ TAZ control induction of fundamental cellular processes in response to matrix stiffness and TGFβ1 signalling in the context of fibrosis and oncogenesis. [52] [53] [54] [55] [56] [57] [58] [59] [60] Published reports suggest that YAP/TAZ signalling crosstalk with TGFβ1 signalling. 54, 60, 63, 70 It is well-known that TGFβ1 binds to its receptors and induces EMT through Smad-dependent and Smad-independent pathways. 9,49-51,70-73 The nuclear accumulation of YAP and TAZ determines its transcriptional activity.
Here, we found that TRPV4 is essential for the nuclear translocation of YAP/TAZ in response to matrix stiffness and TGFβ1 in NMEKs, suggesting a possible regulatory role of TRPV4 mechanosensing in YAP/TAZ transcriptional activity. The increased expression of YAP and TAZ proteins may modulate nuclear availability of these proteins under multiple pathophysiological conditions. [52] [53] [54] [55] [56] [57] [58] [59] [60] Here, we found that TRPV4 deletion blocked both matrix stiffness-induced and TGFβ1-induced expression of YAP and TAZ proteins in NMEKs, suggesting an additional mechanism of regulating YAP/TAZ activity by TRPV4. It has been reported that matrix stiffness regulates YAP/TAZ localization to the nucleus by increasing cytoskeletal tension.
57,58
Previously, we reported that TGFβ1-induced cytoskeletal remodelling in fibroblasts is regulated in part by TRPV4. 29 Here, we found that TAZ nuclear localization in response to TGFβ1 is dependent on cytoskeletal remodelling. Our current results suggest that TRPV4 may promote EMT in NMEKs via cytoskeletal remodelling that regulates YAP/TAZ nuclear translocation.
We found that both WT and TRPV4 KO NMEKs were sensitive to TGFβ1-induced Smad2/3 activation. This suggests that TRPV4
mediates EMT via a Smad-independent pathway. However, both stiff matrices and TGFβ1-induced activation of AKT in WT NMEKs, which was absent in TRPV4 KO NMEKs. It is known that TGFβ1-induced EMT is regulated by activation of the PI3K/AKT pathway. [49] [50] [51] 71, 73 It is also reported that increasing stiffness regulates TGFβ1-induced EMT through PI3K/AKT signalling. 23 In this study, increases in the ECAD expression accompanied by increased expression of mesenchymal markers in an in vivo fibrosis model. 17, 62 Our present data showed that TRPV4 is associated with bleomycin-induced EMT. This is in agreement with our recent finding that TRPV4 deletion protects mice against bleomycin-induced skin fibrosis. 30 Intracellular calcium plays an important role in every aspect of cellular life including inducing EMT. [24] [25] [26] [27] [28] 74, 75 It is also unknown how TRPV4 is sensitized by matrix stiffness or TGFβ1. In view of the fact that TRPV4 mediates actin polymerization and integrin signalling, 29, 40, 41 it will be interesting to determine if TRPV4 is sensitized through cytoskeletal remodelling and/or integrin signalling via a feed-forward mechanism. In summary, we report a novel role of TRPV4 channels in regulating matrix stiffness-induced and TGFβ1-induced EMT in normal skin epithelial cells. Furthermore understanding the mechanism by which TRPV4 regulates EMT will support therapeutic targeting of TRPV4 signalling to combat fibrosis, foreign body response and oncogenesis.
| MATERIALS AND METHODS

| Reagents
Anti-α-SMA, GSK2193874 (GSK219), GSK1016790A (GSK101), A23187 (A23; calcium ionophore) were purchased from Sigma-Aldrich were purchased from Matrigen Life Technologies (Brea, CA, USA).
Immunoblotting-related reagents were purchased from Bio-Rad Laboratories (Hercules, CA, USA). All other chemicals were purchased from Sigma or Thermo Fisher Scientific unless otherwise indicated.
| Animals
Trpv4 knock out (TRPV4 KO or TRPV4−/−) mice on a C57BL/6 background were originally generated by Dr. M. Suzuki, Department 
| Cell culture
Primary normal mouse epidermal keratinocytes were derived from the tail of 8-10-week-old WT and TRPV4 KO adult mice as published previously. 79 Briefly, the mouse tail skin was washed with sterile cold PBS, and treated with trypsin (0.25%) for 2 hours at 37°C, 5% CO 2 to separate epidermis and dermis. The peeled epidermis was rinsed thoroughly in PBS and minced in cold keratinocyte specific media (ATCC, Manassas, VA, USA). The cell suspension was pipetted up and down several times, strained, centrifuged and resuspended in media. NMEKs were then seeded in collagen-coated (10 μg/ml) culture flasks. Medium was replaced every 48 hours thereafter. NMEKs were maintained in complete keratinocyte media supplemented with keratinocyte growth kit (ATCC) and penicillin/ streptomycin (Thermo Fisher Scientific). Cells were cultured at 37°C in a humidified atmosphere containing 5% CO 2 and sub-cultured at 70% confluence. Purity of NMEKs was examined by changes in morphology and by analysing alterations of expression of epithelial/keratinocyte specific markers as previously published. 9 For all experiments, NMEKs were seeded on collagen coated (10 μg/ml) plastic or polyacrylamide hydrogels with compliant (0.5 and 1 kPa) and stiff (8 and 25 kPa) matrices followed by treatment with vehicle or TGFβ1 (5 ng/ml).
| Bleomycin-induced murine skin fibrosis model
The bleomycin-induced skin fibrosis model was employed as described previously. 29, 30 Bleomycin was prepared by dissolving bleomycin sulfate (Hospira, Lake Forest, IL, USA) in sterile PBS.
Briefly, 6-month-old WT and TRPV4 KO mice (n = 5 per group) received equal volumes (0.1 ml) of bleomycin (10 mg/kg) or PBS (control). All injections were administered subcutaneously to the shaved dorsal area of the mice every alternate day for 28 days. All mice were euthanized 24 hours after the last dose, and skin tissues were harvested for immunofluorescence staining. Skin samples were snap frozen in liquid nitrogen, embedded in OCT (Sakura Finetek, USA), and stored at −80°C. Cryostat sections (7 μm) were mounted on glass slides. 
| Intracellular calcium influx assay
| Immunofluorescence staining
Normal mouse primary epidermal keratinocytes were grown on collagen coated cover glass or polyacrylamide hydrogels, and treated with or without TGFβ1 for 72 hours. Cells were fixed with 3% SHARMA ET AL.
| 771 paraformaldehyde, permeabilized with 0.1% Triton X-100, washed and blocked with 3% BSA/PBS. Cells were immunostained for ECAD, α-SMA, TRPV4, YAP and TAZ. Bleomycin or vehicle treated mouse skin sections were fixed with acetone, and immunostained for α-SMA, NCAD, ECAD and TRPV4, followed by incubation with Alexa
Fluor 488 or 594 conjugated IgG. Cells were then mounted using Prolong diamond antifade reagent with DAPI. Immunofluorescence intensity was quantified using ImageJ software (NIH), and the results were expressed as integrated density (int. density) (the product of area and mean grey value).
| Immunoblot analysis
Normal mouse primary epidermal keratinocytes were grown on colla- 
| Statistical analysis
All data are expressed as mean ± SEM. Statistical analysis was performed with the Student's t test for two groups or ANOVA for three or more groups using Prism software. A value of P ≤ 0.05 was considered statistically significant.
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